Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19 #MMPMID32853602
Garrigues E; Janvier P; Kherabi Y; Le Bot A; Hamon A; Gouze H; Doucet L; Berkani S; Oliosi E; Mallart E; Corre F; Zarrouk V; Moyer JD; Galy A; Honsel V; Fantin B; Nguyen Y
J Infect 2020[Dec]; 81 (6): e4-e6 PMID32853602show ga
OBJECTIVE: To assess post-discharge persistent symptoms and health-related quality of life (HRQoL) of patients hospitalized in a COVID-19 ward unit more than 100 days after their admission. METHODS: All eligible patients were contacted by phone by trained physicians and were asked to answer to a dedicated questionnaire. Patients managed in hospital ward without needing intensive care were compared with those who were transferred in intensive care units (ICU). RESULTS: We included 120 patients after a mean (+/-SD) of 110.9 (+/-11.1) days following admission. The most frequently reported persistent symptoms were fatigue (55%), dyspnoea (42%), loss of memory (34%), concentration and sleep disorders (28% and 30.8%, respectively). Comparisons between ward- and ICU patients led to no statistically significant differences regarding those symptoms. In both group, EQ-5D (mobility, self-care, pain, anxiety or depression, usual activity) was altered with a slight difference in pain in the ICU group. CONCLUSION: Most patients requiring hospitalization for COVID-19 still have persistent symptoms. While there were few differences between HRQoL between ward and ICU patients, our findings must be confirmed in larger cohorts, including more severe patients.
free
free
free
J+Infect 2020 ; 81 (6): e4-e6
